Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69f43505d1b3ec31c224b32b5d1ec4e2 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-035 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L29-055 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 |
filingDate |
2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c35835b53fb9b2fc16a8faec01698be http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84a6de0103124c27375557aa3c37cf9d |
publicationDate |
2011-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20110039843-A |
titleOfInvention |
Pharmaceutical composition for treating thyroid cancer containing any one or more compounds selected from α-lipoic acid or derivatives thereof as an active ingredient |
abstract |
The present invention relates to a pharmaceutical composition for treating thyroid cancer and health foods containing any one or two or more compounds selected from α-lipoic acid or derivatives thereof, and α-lipoic acid or its active form dihydrolipoic acid is a thyroid-specific gene. For example, it can be used as a novel differentiation inducer of thyroid cancer by promoting the expression of sodium iodine transporter (NIS), thyroid globulin (Tg) or thyroid transcription factor-1 (TTF-1). |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200031219-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150051159-A |
priorityDate |
2009-10-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |